MarketResearch.com logo

Recent Autoimmune Research for August 2014


Severe Psoriasis - Pipeline Review, H2 2014
Topics: Autoimmune, Drug Discovery
Moderate Psoriasis - Pipeline Review, H2 2014
Topics: Autoimmune, Drug Discovery
Psoriasis Partnering 2009-2014
Topics: Autoimmune, Drug Discovery
Systemic Lupus Erythematosus Partnering 2009-2014
Topics: Autoimmune, Drug Discovery
Psoriatic Arthritis Market Info: 2014 ™
Topics: Arthritis, Autoimmune, Prescription Drugs
Psoriasis Market Info™: 2014
Topics: Autoimmune, Research & Development
Plaque Psoriasis (Psoriasis Vulgaris) - Pipeline Review, H2 2014
Topics: Autoimmune, Drug Discovery
Systemic Lupus Erythematosus - Pipeline Review, H2 2014
Topics: Autoimmune, Drug Discovery
Conference Documentation: Immunogenicity
Topics: Autoimmune, Manufacturing, Packaging & Detailing, Research & Development
Frontier Pharma: Psoriasis - Identifying and Commercializing First-in-Class Innovation
Topics: Autoimmune, Research & Development, Drug Discovery
Market Highlights: UK Psoriasis – 2014
Topics: Autoimmune
Regions: United Kingdom
Market Highlights: Spain Ulcerative Colitis – 2014
Topics: Autoimmune, Drug Discovery, Clinical Trial
Regions: Spain
Market Highlights: UK Ulcerative Colitis – 2014
Topics: Autoimmune, Drug Discovery, Clinical Trial
Regions: United Kingdom
Market Highlights: Germany Ulcerative Colitis – 2014
Topics: Autoimmune, Drug Discovery, Clinical Trial
Regions: Germany
Market Highlights: France Ulcerative Colitis – 2014
Topics: Autoimmune, Drug Discovery, Clinical Trial
Regions: France
Market Highlights: Italy Ulcerative Colitis – 2014
Topics: Autoimmune, Drug Discovery, Clinical Trial
Regions: Italy
Market Highlights: UK Systemic Lupus Erythematosus – 2014
Topics: Autoimmune, Drug Discovery
Regions: United Kingdom
Market Highlights: France Systemic Lupus Erythematosus – 2014
Topics: Autoimmune, Drug Discovery
Regions: France
Market Highlights: Japan Systemic Lupus Erythematosus – 2014
Topics: Autoimmune, Drug Discovery
Regions: Japan
Update: Systemic Lupus Erythematosus Pipeline Highlights – 2014
Topics: Autoimmune, Drug Discovery
Product and Pipeline Analysis of the Global Psoriasis Therapeutics Market
Topics: Autoimmune, Drug Discovery
Regions: Global
Chronic Plaque Psoriasis - Pipeline Review, H1 2014
Topics: Autoimmune, Drug Discovery
Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2014
Topics: Autoimmune, Drug Discovery
Market Highlights: Spain Psoriasis – 2014
Topics: Autoimmune
Regions: Spain
Market Highlights: Germany Psoriasis – 2014
Topics: Autoimmune
Regions: Germany
Market Highlights: Japan Ulcerative Colitis – 2014
Topics: Autoimmune, Drug Discovery, Clinical Trial
Regions: Japan
Market Highlights: US Ulcerative Colitis – 2014
Topics: Autoimmune, Drug Discovery, Clinical Trial
Regions: United States
Update: Psoriasis Pipeline Highlights – 2014
Topics: Autoimmune, Research & Development, Drug Discovery
Market Highlights: Spain Systemic Lupus Erythematosus – 2014
Topics: Autoimmune, Drug Discovery
Regions: Spain
Market Highlights: Germany Systemic Lupus Erythematosus – 2014
Topics: Autoimmune, Drug Discovery
Regions: Germany
Market Highlights: Italy Systemic Lupus Erythematosus – 2014
Topics: Autoimmune, Drug Discovery
Regions: Italy
Market Highlights: US Systemic Lupus Erythematosus – 2014
Topics: Autoimmune, Drug Discovery
Regions: United States
Market Highlights: Europe Systemic Lupus Erythematosus – 2014
Topics: Autoimmune, Drug Discovery
Regions: Europe
Psoriasis Treatment: World Drug Market 2013-2023
Topics: Biologics, Autoimmune, Research & Development, Drug Discovery
Regions: Global
Blisibimod (Systemic Lupus Erythematosus and Lupus Nephritis) - Forecast and Market Analysis to 2022
Topics: Autoimmune, Drug Discovery
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Germany Drug Forecast and Market Analysis to 2022
Topics: Autoimmune, Drug Discovery
Regions: Germany
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - UK Drug Forecast and Market Analysis to 2022
Topics: Autoimmune, Drug Discovery
Regions: United Kingdom
Epratuzumab (Systemic Lupus Erythematosus and Lupus Nephritis) - Forecast and Market Analysis to 2022
Topics: Autoimmune, Drug Discovery
Frontier Pharma: Systemic Lupus Erythematosus - Identifying and Commercializing First-in-Class Innovation
Topics: Biologics, Autoimmune, Pharmaceuticals Company Reports, Drug Discovery
Psoriasis - Pipeline Review, H1 2014
Topics: Autoimmune, Drug Discovery
Competitor Analysis: Janus Kinase (JAK) and spleen tyrosine kinase (syk) Inhibitors
Topics: Autoimmune, Drug Discovery
Systemic Psoriasis Therapeutics in Major Developed Markets to 2020 - Continued Uptake of Biologics and Novel Pipeline Drugs to Drive Growth
Topics: Biologics, Autoimmune, Drug Discovery, Biopharmaceuticals, Clinical Trial
Systemic Lupus Erythematosus Partnering 2009-2014
Topics: Autoimmune, Drug Discovery
Drugs for Treating Systemic Lupus Erythematosus: Global Markets
Topics: Autoimmune, Drug Discovery
Regions: Global
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Current and Future Players
Topics: Autoimmune, Drug Discovery
Benlysta (Systemic Lupus Erythematosus and Lupus Nephritis) - Forecast and Market Analysis to 2022
Topics: Autoimmune, Drug Discovery
Rituxan (Systemic Lupus Erythematosus and Lupus Nephritis) - Forecast and Market Analysis to 2022
Topics: Autoimmune, Drug Discovery
Tabalumab (Systemic Lupus Erythematosus and Lupus Nephritis) - Forecast and Market Analysis to 2022
Topics: Autoimmune, Drug Discovery
Atacicept (Systemic Lupus Erythematosus and Lupus Nephritis) - Forecast and Market Analysis to 2022
Topics: Autoimmune, Drug Discovery
Lupuzor (Systemic Lupus Erythematosus and Lupus Nephritis) - Forecast and Market Analysis to 2022
Topics: Autoimmune, Drug Discovery


Prev  | 1  | 2  | Next    

 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.